Neuron specific reduction in CuZnSOD is not sufficient to initiate a full sarcopenia phenotype
- PMID: 25917273
- PMCID: PMC5022075
- DOI: 10.1016/j.redox.2015.04.005
Neuron specific reduction in CuZnSOD is not sufficient to initiate a full sarcopenia phenotype
Abstract
Our previous studies showed that adult (8 month) mice lacking CuZn-superoxide dismutase (CuZnSOD, Sod1KO mice) have neuromuscular changes resulting in dramatic accelerated muscle atrophy and weakness that mimics age-related sarcopenia. We have further shown that loss of CuZnSOD targeted to skeletal muscle alone results in only mild weakness and no muscle atrophy. In this study, we targeted deletion of CuZnSOD specifically to neurons (nSod1KO mice) and determined the effect on muscle mass and weakness. The nSod1KO mice show a significant loss of CuZnSOD activity and protein level in brain and spinal cord but not in muscle tissue. The masses of the gastrocnemius, tibialis anterior and extensor digitorum longus (EDL) muscles were not reduced in nSod1KO compared to wild type mice, even at 20 months of age, although the quadriceps and soleus muscles showed small but statistically significant reductions in mass in the nSod1KO mice. Maximum isometric specific force was reduced by 8-10% in the gastrocnemius and EDL muscle of nSod1KO mice, while soleus was not affected. Muscle mitochondrial ROS generation and oxidative stress measured by levels of reactive oxygen/nitrogen species (RONS) regulatory enzymes, protein nitration and F2-isoprostane levels were not increased in muscle from the nSod1KO mice. Although we did not find evidence of denervation in the nSod1KO mice, neuromuscular junction morphology was altered and the expression of genes associated with denervation acetylcholine receptor subunit alpha (AChRα), the transcription factor, Runx1 and GADD45α) was increased, supporting a role for neuronal loss of CuZnSOD initiating alterations at the neuromuscular junction. These results and our previous studies support the concept that CuZnSOD deficits in either the motor neuron or muscle alone are not sufficient to initiate a full sarcopenic phenotype and that deficits in both tissues are required to recapitulate the loss of muscle observed in Sod1KO mice.
Keywords: CuZnSOD; Muscle atrophy; Neuromuscular junction; Oxidative stress; Sarcopenia.
Published by Elsevier B.V.
Figures
Similar articles
-
Accelerated sarcopenia in Cu/Zn superoxide dismutase knockout mice.Free Radic Biol Med. 2019 Feb 20;132:19-23. doi: 10.1016/j.freeradbiomed.2018.06.032. Epub 2018 Jul 2. Free Radic Biol Med. 2019. PMID: 30670156 Free PMC article. Review.
-
Redox homeostasis and age-related deficits in neuromuscular integrity and function.J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):881-906. doi: 10.1002/jcsm.12223. Epub 2017 Jul 26. J Cachexia Sarcopenia Muscle. 2017. PMID: 28744984 Free PMC article. Review.
-
Dietary restriction attenuates age-associated muscle atrophy by lowering oxidative stress in mice even in complete absence of CuZnSOD.Aging Cell. 2012 Oct;11(5):770-82. doi: 10.1111/j.1474-9726.2012.00843.x. Epub 2012 Aug 2. Aging Cell. 2012. PMID: 22672615 Free PMC article.
-
The lack of CuZnSOD leads to impaired neurotransmitter release, neuromuscular junction destabilization and reduced muscle strength in mice.PLoS One. 2014 Jun 27;9(6):e100834. doi: 10.1371/journal.pone.0100834. eCollection 2014. PLoS One. 2014. PMID: 24971750 Free PMC article.
-
Muscle mitochondrial catalase expression prevents neuromuscular junction disruption, atrophy, and weakness in a mouse model of accelerated sarcopenia.J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1582-1596. doi: 10.1002/jcsm.12768. Epub 2021 Sep 24. J Cachexia Sarcopenia Muscle. 2021. PMID: 34559475 Free PMC article.
Cited by
-
Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle.FASEB J. 2016 Nov;30(11):3771-3785. doi: 10.1096/fj.201600450R. Epub 2016 Aug 22. FASEB J. 2016. PMID: 27550965 Free PMC article.
-
Using MRI to measure in vivo free radical production and perfusion dynamics in a mouse model of elevated oxidative stress and neurogenic atrophy.Redox Biol. 2019 Sep;26:101308. doi: 10.1016/j.redox.2019.101308. Epub 2019 Aug 21. Redox Biol. 2019. PMID: 31470261 Free PMC article.
-
Accelerated sarcopenia in Cu/Zn superoxide dismutase knockout mice.Free Radic Biol Med. 2019 Feb 20;132:19-23. doi: 10.1016/j.freeradbiomed.2018.06.032. Epub 2018 Jul 2. Free Radic Biol Med. 2019. PMID: 30670156 Free PMC article. Review.
-
Role of reactive oxygen species in age-related neuromuscular deficits.J Physiol. 2016 Apr 15;594(8):1979-88. doi: 10.1113/JP270564. J Physiol. 2016. PMID: 26870901 Free PMC article. Review.
-
Redox homeostasis and age-related deficits in neuromuscular integrity and function.J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):881-906. doi: 10.1002/jcsm.12223. Epub 2017 Jul 26. J Cachexia Sarcopenia Muscle. 2017. PMID: 28744984 Free PMC article. Review.
References
-
- Muller F.L., Song W., Liu Y., Chaudhuri A., Pieke-Dahl S., Strong R., Huang T.T., Epstein C.J., Roberts L.J., 2nd, Csete M. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radical Biology and Medicine. 2006;40(11):1993–2004. 16716900 - PubMed
-
- Jang Y.C., Lustgarten M.S., Liu Y., Muller F.L., Bhattacharya A., Liang H., Salmon A.B., Brooks S.V., Larkin L., Hayworth C.R. Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration. FASEB Journal. 2010;24(5):1376–1390. 20040516 - PMC - PubMed
-
- Larkin L.M., Davis C.S., Sims-Robinson C., Kostrominova T.Y., Van Remmen H., Richardson A., Feldman E.L., Brooks S.V. Skeletal muscle weakness due to deficiency of CuZn-superoxide dismutase is associated with loss of functional innervation. American Journal of Physiology – Regulatory, Integrative and Comparative Physiology. 2011;301(5):R1400–R1407. 21900648 - PMC - PubMed
-
- Sakellariou G.K., Davis C.S., Shi Y., Ivannikov M.V., Zhang Y., Vasilaki A., Macleod G.T., Richardson A., Van Remmen H., Jackson M.J. Neuron-specific expression of CuZnSOD prevents the loss of muscle mass and function that occurs in homozygous CuZnSOD-knockout mice. FASEB Journal. 2014;28(4):1666–1681. 24378874 - PMC - PubMed
-
- Zhang Y., Davis C., Sakellariou G.K., Shi Y., Kayani A.C., Pulliam D., Bhattacharya A., Richardson A., Jackson M.J., McArdle A. CuZnSOD gene deletion targeted to skeletal muscle leads to loss of contractile force but does not cause muscle atrophy in adult mice. FASEB Journal. 2013;27(9):3536–3548. 23729587 - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous